Value of free-to-total prostate-specific antigen ratio for detection and staging of prostate cancer
โ Scribed by Y. Furuya; K. Akakura; H. Ito
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 74 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1341-9625
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND. The American Joint Committee on Cancer (AJCC) staging system for prostate cancer is based primarily based on clinical tumor (T) classification. In this article, the authors summarize arguments for incorporating additional pretreatment parameters and creating a new stagin
## BACKGROUND. Prostate specific antigen (PSA) is the most useful marker for prostate carcinoma (Cap). However, the sensitivity and specificity for PSA are not sufficient for the diagnosis of organ-confined prostate carcinoma. Recent studies have revealed that anti-PSA antibody identifies both PSA